Hai-Yang Xu Selected Research

tri-o-cresyl phosphate (TOCP)

1/2018	Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.
1/2017	Autophagy in Tri-o-cresyl Phosphate-Induced Delayed Neurotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai-Yang Xu Research Topics

Disease

3	Glioma (Gliomas) 03/2017 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 03/2017 - 01/2016
2	Neoplasms (Cancer) 01/2017 - 01/2016
1	Postoperative Nausea and Vomiting (PONV) 05/2020
1	Pain (Aches) 05/2020
1	Postoperative Pain 05/2020
1	Conversion Disorder (Astasia Abasia) 10/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Ataxia (Dyssynergia) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Neoplasm Metastasis (Metastasis) 03/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Neuroblastoma 01/2017

Drug/Important Bio-Agent (IBA)

2	tri-o-cresyl phosphate (TOCP)IBA 01/2018 - 01/2017
2	granatin BIBA 01/2017 - 01/2016
1	Opioid Analgesics (Opioids)IBA 05/2020
1	CarbonIBA 10/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	OrganophosphatesIBA 01/2018
1	Aligeron (AS 2)IBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	Caspase 3 (Caspase-3)IBA 01/2016
1	BromidesIBA 01/2016
1	DAPIIBA 01/2016

Therapy/Procedure

1	Electrodes (Electrode) 10/2018